Jiayuh Lin

1.6k total citations
19 papers, 1.3k citations indexed

About

Jiayuh Lin is a scholar working on Molecular Biology, Oncology and Dermatology. According to data from OpenAlex, Jiayuh Lin has authored 19 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Oncology and 4 papers in Dermatology. Recurrent topics in Jiayuh Lin's work include Skin Protection and Aging (4 papers), Cytokine Signaling Pathways and Interactions (4 papers) and Cancer Research and Treatments (3 papers). Jiayuh Lin is often cited by papers focused on Skin Protection and Aging (4 papers), Cytokine Signaling Pathways and Interactions (4 papers) and Cancer Research and Treatments (3 papers). Jiayuh Lin collaborates with scholars based in United States and China. Jiayuh Lin's co-authors include Gary J. Fisher, John J. Voorhees, Harvinder Talwar, Chenglong Li, James R. Fuchs, Pui‐Kai Li, Zhongfa Liu, Zhiliang Xie, Kenneth K. Chan and Fiona McPhillips and has published in prestigious journals such as Journal of Clinical Investigation, PLoS ONE and Oncogene.

In The Last Decade

Jiayuh Lin

19 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jiayuh Lin United States	13	707	429	203	177	143	19	1.3k
Sivaprakasam Balasubramanian United States	21	817 1.2×	145 0.3×	175 0.9×	102 0.6×	136 1.0×	30	1.4k
Zhiqi Song China	18	465 0.7×	113 0.3×	97 0.5×	66 0.4×	47 0.3×	39	850
Scott L. Wehage United States	12	955 1.4×	129 0.3×	108 0.5×	25 0.1×	112 0.8×	14	1.2k
Fernanda Faião‐Flores Brazil	18	480 0.7×	102 0.2×	146 0.7×	94 0.5×	26 0.2×	32	860
BI Zhi-gang China	14	470 0.7×	185 0.4×	123 0.6×	35 0.2×	33 0.2×	23	806
Richard M. Niles United States	24	1.2k 1.7×	100 0.2×	246 1.2×	32 0.2×	249 1.7×	64	1.8k
An Van Laethem Belgium	13	388 0.5×	353 0.8×	119 0.6×	10 0.1×	100 0.7×	27	816
Arief Budiyanto Indonesia	13	459 0.6×	706 1.6×	204 1.0×	8 0.0×	202 1.4×	28	1.4k
Soesiawati R. Darjatmoko United States	19	567 0.8×	37 0.1×	65 0.3×	41 0.2×	52 0.4×	34	1.2k
Rui Ge China	21	656 0.9×	88 0.2×	242 1.2×	12 0.1×	53 0.4×	87	1.6k

Countries citing papers authored by Jiayuh Lin

Since Specialization

Citations

This map shows the geographic impact of Jiayuh Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiayuh Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiayuh Lin more than expected).

Fields of papers citing papers by Jiayuh Lin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiayuh Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiayuh Lin. The network helps show where Jiayuh Lin may publish in the future.

Co-authorship network of co-authors of Jiayuh Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Jiayuh Lin. A scholar is included among the top collaborators of Jiayuh Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiayuh Lin. Jiayuh Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Lin, Jiayuh, et al.. (2024). Synergistic effect of bazedoxifene and abemaciclib co‑treatment in triple‑negative breast cancer cells in vitro. Oncology Letters. 28(6). 1 indexed citations

Yang, Xiaozhi, et al.. (2021). A novel small molecule LLL12B inhibits STAT3 signaling and sensitizes ovarian cancer cell to paclitaxel and cisplatin. PLoS ONE. 16(4). e0240145–e0240145. 11 indexed citations

Zhao, Chengguang, Lehe Yang, Feng Zhou, et al.. (2020). Feedback activation of EGFR is the main cause for STAT3 inhibition-irresponsiveness in pancreatic cancer cells. Oncogene. 39(20). 3997–4013. 28 indexed citations

Kim, Dong‐Il, Jia Liao, Margo P. Emont, et al.. (2018). An OLTAM system for analysis of brown/beige fat thermogenic activity. International Journal of Obesity. 42(4). 939–945. 8 indexed citations

Wei, Jia, Ling Ma, Chenglong Li, et al.. (2018). Targeting Upstream Kinases of STAT3 in Human Medulloblastoma Cells. Current Cancer Drug Targets. 19(7). 571–582. 11 indexed citations

Bid, Hemant K., Doris A. Phelps, Denis C. Guttridge, et al.. (2016). The Bromodomain BET Inhibitor JQ1 Suppresses Tumor Angiogenesis in Models of Childhood Sarcoma. Molecular Cancer Therapeutics. 15(5). 1018–1028. 66 indexed citations

Wu, Xiaojuan, et al.. (2015). Abstract A177: Repositioning Bazedoxifene as a novel inhibitor of IL-6/GP130 signaling for pancreatic cancer therapy. Molecular Cancer Therapeutics. 14(12_Supplement_2). A177–A177. 1 indexed citations

Du, Liping, Zhiliang Xie, Lai‐Chu Wu, et al.. (2012). Reactivation of RASSF1A in Breast Cancer Cells by Curcumin. Nutrition and Cancer. 64(8). 1228–1235. 67 indexed citations

Liu, Yan, Chenglong Li, & Jiayuh Lin. (2010). STAT3 as a Therapeutic Target for Glioblastoma. Anti-Cancer Agents in Medicinal Chemistry. 10(7). 512–519. 29 indexed citations

10.

Fuchs, James R., Bulbul Pandit, Deepak K. Bhasin, et al.. (2009). Structure–activity relationship studies of curcumin analogues. Bioorganic & Medicinal Chemistry Letters. 19(7). 2065–2069. 98 indexed citations

11.

Liu, Zhongfa, Zhiliang Xie, W.P. Jones, et al.. (2008). Curcumin is a potent DNA hypomethylation agent. Bioorganic & Medicinal Chemistry Letters. 19(3). 706–709. 258 indexed citations

12.

Yang, Eric V., Seung-Jae Kim, Elise L. Donovan, et al.. (2008). 11. Norepinephrine upregulates VEGF, IL-6, and IL-8 expression in human melanoma tumor cell lines: Implications for stress-related enhancement of tumor progression. Brain Behavior and Immunity. 22(4). 3–3. 14 indexed citations

13.

Deng, Qian, et al.. (2004). A modified p53 enhances apoptosis in sarcoma cell lines mediated by doxorubicin. British Journal of Cancer. 90(6). 1285–1292. 13 indexed citations

14.

Lin, Jiayuh, et al.. (2001). Suppression activity of pro-apoptotic gene products in cancer cells, a potential application for cancer gene therapy.. PubMed. 21(2A). 831–9. 12 indexed citations

15.

Chung, Jin Ho, Sewon Kang, James Varani, et al.. (2000). Decreased Extracellular-Signal-Regulated Kinase and Increased Stress-Activated MAP Kinase Activities in Aged Human Skin In Vivo. Journal of Investigative Dermatology. 115(2). 177–182. 144 indexed citations

16.

Pochampally, Radhika, Changgong Li, Wenge Lu, et al.. (2000). Temperature-Sensitive Mutants of p53 Homologs. Biochemical and Biophysical Research Communications. 279(3). 1001–1010. 13 indexed citations

17.

Fisher, Gary J., Harvinder Talwar, Jiayuh Lin, & John J. Voorhees. (1999). Molecular Mechanisms of Photoaging in Human Skin In Vivo and Their Prevention by All‐Trans Retinoic Acid. Photochemistry and Photobiology. 69(2). 154–157. 86 indexed citations

18.

Fisher, Gary J., Harvinder Talwar, Jiayuh Lin, & John J. Voorhees. (1999). Molecular Mechanisms of Photoaging in Human Skin In Vivo and Their Prevention by All-Trans Retinoic Acid. Photochemistry and Photobiology. 69(2). 154–154. 103 indexed citations

19.

Fisher, Gary J., Harvinder Talwar, Jiayuh Lin, et al.. (1998). Retinoic acid inhibits induction of c-Jun protein by ultraviolet radiation that occurs subsequent to activation of mitogen-activated protein kinase pathways in human skin in vivo.. Journal of Clinical Investigation. 101(6). 1432–1440. 296 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact